Why Is Starling Oncology, Inc. (NASDAQ: STLN) Stock Up Today?

Starling Oncology, Inc. (NASDAQ: STLN) Summary

Starling Oncology, Inc. (NASDAQ: STLN) is trading down -13.48% at $3.76, reflecting a negative shift in investor sentiment today. The stock opened at $4.10 and has moved between $3.67 and $4.24 so far.

Trading volume is 4789035, which is 163% above its average, and the price action suggests selling interest.

Technically, STLN on the NASDAQ is trading below its 50-day moving average of $6.36 and below its 200-day moving average of $4.77, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns STLN a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +81.62% in 1 month ($6.82), +108.88% in 1 year ($7.84), and -100.00% in 5 years ($0.00).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.